Onyx Pharmaceuticals, Inc., an Amgen subsidiary

๐Ÿ“ South San Francisco, United States๐Ÿ—“ Founded 1991๐Ÿ‘ฅ 186 employees๐Ÿ’ฐ Last funded 1992
Formerly based in South San Francisco, California, Onyx Pharmaceuticals was engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. Amgen acquired Onyx Pharmaceuticals in 2013. See our Community Guidelines: bit.ly/smcgl
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
1991
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Onyx Pharmaceuticals, Inc., an Amgen subsidiary?
Onyx Pharmaceuticals, Inc., an Amgen subsidiary has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Onyx Pharmaceuticals, Inc., an Amgen subsidiary last raise funding?
The most recent investment in Onyx Pharmaceuticals, Inc., an Amgen subsidiary recorded on gritt.io was in 1992.
When was Onyx Pharmaceuticals, Inc., an Amgen subsidiary founded?
Onyx Pharmaceuticals, Inc., an Amgen subsidiary was founded in 1991.
What industry is Onyx Pharmaceuticals, Inc., an Amgen subsidiary in?
Onyx Pharmaceuticals, Inc., an Amgen subsidiary operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Onyx Pharmaceuticals, Inc., an Amgen subsidiary based?
Onyx Pharmaceuticals, Inc., an Amgen subsidiary is headquartered in South San Francisco, United States.